# Clinical Significance of Liquid Biopsy in Brain Tumor Patients: a 5-ALA Guided Approach

> **NCT07420543** · — · RECRUITING · sponsor: **Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta** · enrollment: 30 (estimated)

## Conditions studied

- Brain Tumors and/or Solid Tumors Including
- Glioblastoma
- Glioblastoma (GBM)
- Glioblastoma - Category

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07420543
- **Lead sponsor:** Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-01-18
- **Primary completion:** 2026-05
- **Final completion:** 2027-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07420543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07420543, "Clinical Significance of Liquid Biopsy in Brain Tumor Patients: a 5-ALA Guided Approach". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07420543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*